SE450930B - Farmaceutisk beredning innehallande prostacyklin eller vissa derivat derav - Google Patents

Farmaceutisk beredning innehallande prostacyklin eller vissa derivat derav

Info

Publication number
SE450930B
SE450930B SE7904284A SE7904284A SE450930B SE 450930 B SE450930 B SE 450930B SE 7904284 A SE7904284 A SE 7904284A SE 7904284 A SE7904284 A SE 7904284A SE 450930 B SE450930 B SE 450930B
Authority
SE
Sweden
Prior art keywords
solution
buffer
active compound
amino acid
prostacyclin
Prior art date
Application number
SE7904284A
Other languages
English (en)
Swedish (sv)
Other versions
SE7904284L (sv
Inventor
I S Watts
P H Marsden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7904284L publication Critical patent/SE7904284L/
Publication of SE450930B publication Critical patent/SE450930B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7904284A 1978-05-17 1979-05-16 Farmaceutisk beredning innehallande prostacyklin eller vissa derivat derav SE450930B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17

Publications (2)

Publication Number Publication Date
SE7904284L SE7904284L (sv) 1979-11-18
SE450930B true SE450930B (sv) 1987-08-17

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904284A SE450930B (sv) 1978-05-17 1979-05-16 Farmaceutisk beredning innehallande prostacyklin eller vissa derivat derav

Country Status (28)

Country Link
US (1) US4335139A (nl)
EP (1) EP0005768B1 (nl)
JP (1) JPS54163809A (nl)
KR (1) KR830000527B1 (nl)
AT (2) AT365926B (nl)
AU (1) AU525695B2 (nl)
BE (1) BE876296A (nl)
CA (1) CA1141661A (nl)
CH (1) CH641044A5 (nl)
CS (1) CS214798B2 (nl)
DE (2) DE2966046D1 (nl)
DK (1) DK156004C (nl)
ES (1) ES480597A1 (nl)
FI (1) FI68359C (nl)
FR (1) FR2425856A1 (nl)
GR (1) GR68452B (nl)
HU (1) HU182746B (nl)
IL (1) IL57298A (nl)
IT (1) IT1116840B (nl)
LU (1) LU81272A1 (nl)
MC (1) MC1265A1 (nl)
NL (1) NL7903871A (nl)
NZ (1) NZ190462A (nl)
PH (1) PH15850A (nl)
PL (1) PL134004B1 (nl)
SE (1) SE450930B (nl)
SU (1) SU978715A3 (nl)
ZA (1) ZA787353B (nl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
KR0158870B1 (ko) * 1988-06-17 1998-12-01 마틴 에이. 로쓰블랫 폐순환 승압의 치료, 예방 또는 진단용 조성물
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
ATE424399T1 (de) * 2005-06-29 2009-03-15 Verisfield Uk Ltd Pharmazeutische zusammensetzungen von risperidon in wässriger lösung
CA2641393C (en) 2006-02-03 2014-12-16 Scidose Llc Novel epoprostenol formulation and method of making thereof
KR101693049B1 (ko) 2007-09-07 2017-01-04 유나이티드 세러퓨틱스 코오포레이션 그람 음성 박테리아에 대한 선택적인 살균 활성을 갖는 완충 용액 및 이의 이용방법
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
NL7805402A (nl) * 1977-05-20 1978-11-22 Wellcome Found Werkwijze voor de geneeskundige toepassing van prosta- cycline of zijn dihydroderivaat in combinatie met een fosfodiesterase-inhibitor.

Also Published As

Publication number Publication date
BE876296A (fr) 1979-11-16
DK156004C (da) 1989-11-06
FR2425856B1 (nl) 1982-06-25
FI68359C (fi) 1985-09-10
DE2920020A1 (de) 1979-11-29
ZA787353B (en) 1980-08-27
ES480597A1 (es) 1980-08-16
IL57298A0 (en) 1979-09-30
FI68359B (fi) 1985-05-31
EP0005768B1 (en) 1983-08-10
MC1265A1 (fr) 1980-03-28
IT1116840B (it) 1986-02-10
CA1141661A (en) 1983-02-22
DE2920020C2 (nl) 1988-09-01
DE2966046D1 (en) 1983-09-15
PL134004B1 (en) 1985-07-31
EP0005768A1 (en) 1979-12-12
IL57298A (en) 1983-09-30
AU525695B2 (en) 1982-11-25
NL7903871A (nl) 1979-11-20
AU4704279A (en) 1979-11-22
PL215627A1 (nl) 1981-08-07
LU81272A1 (fr) 1979-12-07
CH641044A5 (de) 1984-02-15
JPS6358810B2 (nl) 1988-11-17
ATE4411T1 (de) 1983-08-15
SE7904284L (sv) 1979-11-18
US4335139A (en) 1982-06-15
AT365926B (de) 1982-02-25
DK201879A (da) 1979-11-18
FR2425856A1 (fr) 1979-12-14
JPS54163809A (en) 1979-12-26
IT7949064A0 (it) 1979-05-16
SU978715A3 (ru) 1982-11-30
FI791565A (fi) 1979-11-18
NZ190462A (en) 1982-05-31
HU182746B (en) 1984-03-28
KR830000527B1 (ko) 1983-03-12
ATA363479A (de) 1981-07-15
GR68452B (nl) 1981-12-30
CS214798B2 (en) 1982-05-28
DK156004B (da) 1989-06-12
PH15850A (en) 1983-04-13

Similar Documents

Publication Publication Date Title
US5036060A (en) Cyclophosphamide
SE450930B (sv) Farmaceutisk beredning innehallande prostacyklin eller vissa derivat derav
BR112018008017B1 (pt) Composição farmacêutica líquida, uso de uma composição farmacêutica líquida, método de preparação de uma composição farmacêutica líquida, kit farmacêutico e sistema de fornecimento de injeçãosubcutânea
KR101024511B1 (ko) 올리고펩티드 및 에테르화된 시클로덱스트린을 포함하는액상 제제
JPS61165322A (ja) スパガリン類の注射用凍結乾燥製剤
KR20200033265A (ko) Il-15 단백질 복합체 약학 조성물 및 이의 용도
EA024937B1 (ru) Лиофилизированные препараты fgf-18
CN104689297A (zh) 醋酸奥曲肽冻干粉针制剂及其制备方法
JPH0314520A (ja) インターロイキン―１組成物
PT85561B (pt) Processo para a preparacao de novas formas de aplicacao de alta-interferao(oes)
JP3100058B2 (ja) 線維芽細胞成長因子を含む安定な医薬組成物
EP3040067A1 (en) Chlorogenic acid powder-injection and preparation method thereof
JP6830136B2 (ja) Ｎ−ホルミルピぺリジン含有量が低減されている、及び／又は、凍結乾燥ケーキの崩潰又は収縮が抑制されている、製剤
JP2015224219A (ja) 凍結乾燥製剤
CN113891725B (zh) 包含血管紧张素ii的固态组合物及其制备方法、使用方法、用途
IE48231B1 (en) Pharmaceutical formulations containing prostaglandin compounds
CN103239416B (zh) 一种单硝酸异山梨酯的注射用组合物及其制备方法
EP3054924A1 (en) Stable pharmaceutical formulations of caspofungin
EP0331934A1 (en) New pharmaceutical compositions containing thymosin alpha 1
KR20130070556A (ko) 유기용매 무함유 젬시타빈 수용액 조성물
Niazi et al. Fluorocarbon aerosol propellants IV: Pharmacokinetics of trichloromonofluoromethane following single and multiple dosing in dogs
JPH05345729A (ja) カルシトニン類の安定化組成物および安定化法
JP6510737B1 (ja) Ｎ−ホルミルピぺリジン含有量が低減されている、及び／又は、凍結乾燥ケーキの崩潰又は収縮が抑制されている、製剤
TW202404594A (zh) 醫藥組合物
CN116685309A (zh) 改善的冻干制剂

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7904284-2

Effective date: 19900518

Format of ref document f/p: F